Clinical Trials Browser

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

NCT07420751 2026-04-28

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Phase NA Active not recruiting

18 enrolled

CNS

Neurofibromatosis 2, Hearing Loss

NCT06036407 2026-04-14

HEAR

Phase NA Completed

476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Phase NA Completed

55 enrolled

Head & Neck

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT05582551 2025-12-22

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Phase NA Recruiting

146 enrolled

Neoplasms, Peripheral Nervous System Diseases, Hearing Loss

NCT02310399 2025-10-30

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Phase NA Recruiting

20 enrolled

Deafness, Hearing Loss

Clinical Trials

TIMELY REHAB

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

HEAR

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves